Potential of [18F]-Fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas
暂无分享,去创建一个
F. Lamare | M. Hatt | T. Merlin | M. Hatt | P. Fernandez | F. Lamare | B. Figueiredo | H. Clermont-Gallerande | D. Vimont | P. Fernandez | B. Figueiredo | T. Merlin | H. Clermont-Gallerande | D. Vimont
[1] J. Overgaard,et al. Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.
[2] Richard A Popple,et al. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. , 2002, International journal of radiation oncology, biology, physics.
[3] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[5] Roland Bares,et al. Hypoxia-imaging with 18F-Misonidazole and PET: Changes of kinetics during radiotherapy of head-and-neck cancer , 2007 .
[6] Roland Bares,et al. Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[8] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[9] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[10] Christian Roux,et al. A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET , 2009, IEEE Transactions on Medical Imaging.
[11] Olivier Barret,et al. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] F. Mottaghy,et al. Intensity-Modulated Radiotherapy for Prostate Cancer Implementing Molecular Imaging with 18F-Choline PET-CT to Define a Simultaneous Integrated Boost , 2010, Strahlentherapie und Onkologie.
[13] M. Baumann,et al. Zwei oder vier Stunden [18F]FMISO-PET in Kopf-Hals-Karzinomen: , 2011 .
[14] L. Gianolli,et al. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma , 2011, Strahlentherapie und Onkologie.
[15] J. Steinbach,et al. Two or four hour [¹⁸F]FMISO-PET in HNSCC. When is the contrast best? , 2010, Nuklearmedizin. Nuclear medicine.
[16] Vincent Gregoire,et al. Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. , 2011, Seminars in radiation oncology.
[17] Wade P. Smith,et al. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] J. Steinbach,et al. Two or four hour [18F]FMISO-PET in HNSCC , 2011, Nuklearmedizin.
[19] Dimitris Visvikis,et al. Impact of the accuracy of automatic tumour functional volume delineation on radiotherapy treatment planning , 2012, Physics in medicine and biology.
[20] P. Vaupel,et al. Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas , 2012, Strahlentherapie und Onkologie.
[21] Michael Baumann,et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Keiichi Magota,et al. High Reproducibility of Tumor Hypoxia Evaluated by 18F-Fluoromisonidazole PET for Head and Neck Cancer , 2013, The Journal of Nuclear Medicine.
[23] 岡本祥三. High reproducibility of tumor hypoxia evaluated by 18 F-fluoromisonidazole PET for head and neck cancer. , 2014 .